Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2025

Jul 1, 2025

61842_rns_2025-07-01_4a0cbb88-6773-424a-8098-a0f527866486.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 47406200 Fax: +91 44 47406190 E-mail: [email protected] www.solara.co.in

July 01, 2025

The BSE Limited The National Stock Exchange of India
Phiroze Jeejeebhoy Towers Limited
Dalal Street, Mumbai – 400 001 Exchange Plaza, C-1, Block G, Bandra-Kurla
Complex, Bandra (E), Mumbai – 400 051
Scrip Code: 541540, 890202 Scrip Code: SOLARA, SOLARAPP1

Dear Sir / Madam,

Subject: Credit Rating

Pursuant to Regulation 30(6) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that based on rating assessment undertaken by Crisil Ratings Limited ("CRISIL"), following rating has been received by the Company.

Please find below details of the same:

Credit Rating Agency Crisil Ratings
Limited
Instrument Credit Rating for Rs. 1484 Crores Bank Loan Facilities
(Long Term and Short Term)
Long Term Rating Crisil BBB/stable
(outlook revised from Negative; Rating- reaffirmed)
Short term Rating Crisil A3+ (Reaffirmed)

The rating letter of CRISIL is attached herewith.

We request you to take the above information on your records and disseminate.

Thanking You,

Yours Faithfully, For Solara Active Pharma Sciences Limited

Pooja J Digitally signed by Pooja J

DN: cn=Pooja J, [email protected] Date: 2025.07.01 17:05:07 +05'30'

Pooja Jaya Kumar Company Secretary and Compliance Officer Membership No: A57415

CONFIDENTIAL

RL/SOAPSL/367157/BLR/0425/115211 April 17, 2025

Mr. Ramesh Swamynathan Finance - Head Solara Active Pharma Sciences Limited 201, Devavrata, Sector 17, Vashi Thane - 400703

Dear Mr. Ramesh Swamynathan,

Re: Review of Crisil Ratings on the bank facilities of Solara Active Pharma Sciences Limited

All ratings assigned by Crisil Ratings are kept under continuous surveillance and review.

Please find in the table below the ratings outstanding for the debt instruments/facilities of the company, and the rating actions by Crisil Ratings on the ratings as on date.

Total Bank Loan Facilities Rated Rs.1484 Crore
Long Term Rating (Crisil BBB/Stable (Outlook revised from 'Negative'; Rating Reaffirmed)
Short Term Rating $Crisil A3+ (Reaffirmed)$
Bunkanisa dataily ny mpo kaominina 1

(Bunk-wise details as per Annexure 1)

As per our Rating Agreement, Crisil Ratings would disseminate the ratings, along with the outlook, through its publications and other media, and keep the ratings, along with the outlook, under surveillance over the life of the instrument/facility. Crisil Ratings reserves the right to withdraw, or revise the ratings, along with the outlook, at any time, on the basis of new information, or unavailability of information, or other circumstances which Crisil Ratings believes may have an impact on the ratings. Please visit www.crisilratings.com and search with the name of the rated entity to access the latest rating/s.

In the event of the company not availing the proposed facilities within a period of 180 days from the date of this letter, a fresh letter of revalidation from Crisil Ratings will be necessary.

This letter will remain valid till March 31, 2026. After this date, please insist for a new rating letter (dated later than March 31, 2026).

Should you require any clarification, please feel free to get in touch with us.

With warm regards,

Yours sincerely,

Vaguet Nacket

Jayashree Nandakumar Director - Crisil Ratings

Nivedita Shibu Director - Crisil Ratings

Disclaimer. A rating by Crisil Ratings reflects Crisil Ratings' current opinion on the likelihood of timely payment of the obligations under the rated instrument, and does not constitute an audit of the rated entity by Crisil Ratings. Our ratings are based on information provided by the issuer or obtained by Crisil Ratings from sources it considers reliable. Crisil Ratings does not guarantee the completeness or accuracy of the information on which the rating is based. A rating by Crisil Ratings is not a recommendation to buy / sell or hold the rated instrument; it does not comment on the market price or suitability for a particular investor. Crisil Ratings has a practice of keeping all its ratings under surveillance and ratings are revised as and when circumstances so warrant. Crisil Ratings is not responsible for any errors and especially states that it has no financial liability whatsoever to the subscribers / users / transmitters / distributors of its ratings. Crisil Ratings' criteria are available without charge to the public on the web site, www.crisilr information on any instrument of any company rated by Crisil Ratings, please visit www.crisilnatings.com or contact Customer Service Helpdesk at
Crisil Ratings Limited
Crisil Ratings Limited

Corporate Identity Number: U67100MH2019PLC326247

Registered Office: Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai - 400 072, India. Phone: +91 22 6137 3000 | www.crisilratings.com

Crisil

Ratings

S.No. Bank Facility Bank Amount (Rs.
in Crore)
Outstanding Rating
Cash Credit YES Bank Limited 65 Crisil BBB/Stable
$\overline{2}$ Cash Credit IDFC FIRST Bank Limited 141 Crisil BBB/Stable
3 Cash Credit RBL Bank Limited 70 Crisil BBB/Stable
$\overline{4}$ Cash Credit HDFC Bank Limited 210 Crisil BBB/Stable
5 Cash Credit ICICI Bank Limited 43 Crisil BBB/Stable
6 Letter of Credit HDFC Bank Limited 25 Crisil $A3+$
$\tau$ Letter of Credit IDFC FIRST Bank Limited 9 Crisil A3+
8 Letter of Credit ICICI Bank Limited 57 Crisil A3+
9 Letter of Credit RBL Bank Limited 80 Crisil A3+
10 Long Term Loan Aditya Birla Finance Limited 97 Crisil BBB/Stable
11 Long Term Loan HDFC Bank Limited 47 Crisil BBB/Stable
12 Long Term Loan ICICI Bank Limited 32 Crisil BBB/Stable
13 Long Term Loan YES Bank Limited 45 Crisil BBB/Stable
14 Proposed Working Capital
Facility
57. 563 Crisil BBB/Stable
Total 1484

Annexure 1 - Bank-wise details of various facility classes (outstanding facilities)

Disclaimer: A rating by Crisil Ratings reflects Crisil Ratings' current opinion on the likelihood of timely payment of the obligations under the rated instrument, and does not constitute an audit of the rated entity by Crisil Ratings. Our ratings are based on information provided by the issuer constance the cale instrument, and does
considers reliable. Crisil Ratings does not guarantee the c the public on the web site, www.crisilratings.com. Crisil Ratings or its associates may have other commercial transactions with the company/entity. For the latest rating information on any instrument of any company rated by Crisil Ratings, please visit www.crisiltatings.com or contact Customer Service Helpdesk at
Crisil Ratings Limited com or at 1800-267-1301

Corporate Identity Number: U67100MH2019PLC326247

Registered Office: Lightbridge IT Park, Saki Vihar Road, Andheri East, Mumbai - 400 072, India. Phone: +91 22 6137 3000 | www.crisilratings.com